Biochemistry, Genetics and Molecular Biology
Cytogenetics
100%
Myeloid
35%
Karyotype
34%
B Cell
26%
Genetics
22%
Pennisetum
20%
Chromosome Change
15%
Molecular Genetics
14%
Centromere
14%
Chromosome Breakage
13%
P53
13%
Allele
13%
Trisomy
12%
Cell Oncogene
11%
Overall Survival
11%
Gene Mutation
11%
Pachytene
10%
Fluorescence in Situ Hybridization
10%
Morphology
10%
Metaphase
9%
Intravenous Immunoglobulin
9%
Reciprocal Chromosome Translocation
9%
Chromosome Band
9%
Clonal Evolution
8%
BCR (Gene)
8%
Mosaicism
8%
Genomics
8%
Monosomy
7%
Chromosomal Translocation
7%
Chromosome 9
7%
Immunophenotyping
7%
Chromosome Abnormality
7%
Carcinogenesis
7%
Microarrays
7%
Wild Type
7%
Point Mutation
6%
Epidermal Growth Factor Receptor
6%
Inbred Strain
6%
Tumor Progression
6%
Mouse
6%
Chromosomal Rearrangement
6%
RUNX1
6%
Chromosome 7
5%
Chromosome NOR
5%
BCL6
5%
Interphase
5%
Chromosomal Aberration
5%
Tumor Suppressor Gene
5%
Trisomy 8
5%
Promoter Region
5%
Medicine and Dentistry
Neoplasm
37%
Acute Leukemia
34%
Acute Myeloid Leukemia
30%
Malignant Neoplasm
26%
Fluorescence in Situ Hybridization
25%
Karyotype
23%
Lymphoid Leukemia
22%
Leukemia
20%
Flow Cytometry
13%
Immunophenotyping
13%
Morphology
12%
Overall Survival
11%
De Novo Acute Myeloid Leukemia
10%
T Cell
10%
Diagnosis
10%
Follicular Lymphoma
9%
Clinical Significance
9%
Biological Marker
9%
Immunohistochemistry
9%
B-Cell Chronic Lymphocytic Leukemia
9%
Cumulative Incidence
8%
Chronic Myelogenous Leukemia
8%
B-Cell Lymphoma
8%
P16
8%
Angiosarcoma
8%
Fibroblast Growth Factor Receptor 1
8%
Philadelphia 1 Chromosome
8%
Pediatrics Patient
8%
Endometrial Cancer
8%
Disease Free Survival
7%
Minimal Residual Disease
7%
Lymphoma Cell
7%
Diffuse Large B-Cell Lymphoma
7%
Salivary Gland
7%
Disease
7%
Next Generation Sequencing
6%
Burkitt's Lymphoma
6%
Large-Cell Lymphoma
6%
Tumor Cell
6%
Hypereosinophilia
6%
Leukemia Cell
6%
Myelodysplastic Syndrome
6%
Chromosome Translocation
6%
Multiple Myeloma
5%
Non-Hodgkin Lymphoma
5%
Carcinoma
5%
Immunoglobulin
5%
Germinoma
5%
Molar Pregnancy
5%
Clear Cell Renal Cell Carcinoma
5%
Keyphrases
Mixed-phenotype Acute Leukemia
17%
Immunophenotyping
16%
Lymphoma
13%
Acute Myeloid Leukemia
13%
Chronic Myeloid Leukemia
12%
B-lymphoblastic Leukemia
8%
Breakage
8%
Inv(16)
8%
Endometrial Cancer
8%
Metaphase I
8%
Non-Hodgkin Lymphoma
8%
Myelodysplastic Syndrome
8%
Relapse-free Survival
7%
Bone Marrow Involvement
7%
Immunophenotypic Profile
6%
Co-orientation
6%
B Cells
6%
Cytogenetic Abnormalities
5%
Overall Survival
5%
Chromosome Breakage
5%
Retroperitoneal Lymphadenopathy
5%
Chromosome Rearrangement
5%
Chromosomal Aberrations
5%
Variant Translocation
5%
Chromosome Abnormalities
5%
Tumorigenesis
5%
Additional Cytogenetic Abnormalities
5%
De Novo Acute Myeloid Leukemia
5%
T Cells
5%
